Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences

被引:40
|
作者
Kim, Bokyung [1 ]
机构
[1] Univ Texas Austin, Dept Econ, Austin, TX 78712 USA
关键词
Prescription drug monitoring program; Must-access PDMP; Opioid; Heroin; Opioid overdose; Opioid epidemic;
D O I
10.1016/j.jhealeco.2020.102408
中图分类号
F [经济];
学科分类号
02 ;
摘要
Although supply-side drug policies that limit access to legal opioids have reduced prescription opioid abuse, growing evidence shows that these policies have had the unintended consequence of increasing use of illegal opioids, including heroin. I add to this literature by studying the consequences of must-access prescription drug monitoring programs (PDMPs), which legally require providers to access a state-level database with a patient's prescription history before prescribing controlled substances under certain circumstances. Using a difference-in-differences specification, I find strong evidence that must-access PDMPs have increased heroin death rates. My estimates indicate that two years after implementation, must-access PDMPs were associated with 0.9 more heroin deaths per 100,000 in a half-year period, relative to control states. My results suggest that even if must-access PDMPs reduce prescription opioid deaths, the decrease is offset by a large increase in illegal opioid deaths. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Prescription drug monitoring programs in the United States of America
    Felix, Sausan El Burai
    Mack, Karin
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (04): : 270 - 276
  • [22] Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose
    Guarino, Honoria
    Mateu-Gelabert, Pedro
    Teubl, Jennifer
    Goodbody, Elizabeth
    ADDICTIVE BEHAVIORS, 2018, 86 : 118 - 123
  • [23] Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market
    Clarke, Sarah E. Duhart
    Kral, Alex H.
    Zibbell, Jon E.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 99
  • [24] Prescription drug monitoring programs evaluation: A systematic review of reviews
    Tay, Emma
    Makeham, Meredith
    Laba, Tracey-Lea
    Baysari, Melissa
    DRUG AND ALCOHOL DEPENDENCE, 2023, 247
  • [25] Prescription Drug Monitoring Programs: Examining Limitations and Future Approaches
    Griggs, Christopher A.
    Weiner, Scott G.
    Feldman, James A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2015, 16 (01) : 67 - 70
  • [26] Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement
    Compton, Wilson M.
    Wargo, Eric M.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (11) : 826 - +
  • [27] Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program
    Alexander, John C.
    Silge, Julia
    Jones, Stephanie
    Joshi, Girish P.
    PAIN PHYSICIAN, 2019, 22 (05) : E425 - E433
  • [28] The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey
    Pomerleau, Adam C.
    Nelson, Lewis S.
    Hoppe, Jason A.
    Salzman, Matthew
    Weiss, Paul S.
    Perrone, Jeanmarie
    PAIN MEDICINE, 2017, 18 (05) : 889 - 897
  • [29] Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity
    Brown, Richard
    Riley, Moira R.
    Ulrich, Lydia
    Kraly, Ellen Percy
    Jenkins, Paul
    Krupa, Nicole L.
    Gadomski, Anne
    DRUG AND ALCOHOL DEPENDENCE, 2017, 178 : 348 - 354
  • [30] Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses
    Cerda, Magdalena
    Ponicki, William R.
    Smith, Nathan
    Rivera-Aguirre, Ariadne
    Davis, Corey S.
    Marshall, Brandon D. L.
    Fink, David S.
    Henry, Stephen G.
    Castillo-Carniglia, Alvaro
    Wintemute, Garen J.
    Gaidus, Andrew
    Gruenewald, Paul J.
    Martins, Silvia S.
    EPIDEMIOLOGY, 2020, 31 (01) : 32 - 42